Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 21, 2020
[A CASE OF RENAL CELL CARCINOMA THAT ONCE NIVOLUMAB HAD BEEN EFFECTIVE IN METASTATIC LESION AND MADE PRIMARY TUMOR RESECTABLE]Shigehiro Tsukahara, Yuko Nagatomi, Satoshi Otsubo, et al.
Endocrine-Related Cancer|July 28, 2022
Androgen receptor mutations for precision medicine in prostate cancerMasaki Shiota, Shusuke Akamatsu, Shigehiro Tsukahara, et al.
Urology Practice|April 27, 2023
Adverse Events of Abiraterone Acetate vs EnzalutamideLeandro Blas, Masaki Shiota, Shigehiro Tsukahara, et al.
Clinical Genitourinary Cancer|October 9, 2023
Adverse Events of Cabozantinib Plus Nivolumab Versus Ipilimumab Plus NivolumabLeandro Blas, Masaki Shiota, Shigehiro Tsukahara, et al.
Endocrine-Related Cancer|April 30, 2024
Importance of 3β-hydroxysteroid dehydrogenases and their clinical use in prostate cancerMasaki Shiota, Satoshi Endo, Shigehiro Tsukahara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 14, 2026
Translational Advances in Urothelial Carcinoma: From Bench to BedsideTomohiro Iwasawa, Takuya Tsujino, Shigehiro Tsukahara, et al.
Cancer Medicine|July 27, 2025
Nationwide Genomic Data Analysis of Japanese Prostate Cancer Patients From C-CAT DatabaseShigehiro Tsukahara, Masaki Shiota, Shohei Nagakawa, et al.
Asian Journal of Endoscopic Surgery|November 26, 2024
Laparoscopic Retroperitoneal Lymph Node Dissection After Chemotherapy for Nonseminomatous Testicular Germ-Cell Tumor at a Single CenterMasaki Shiota, Tokiyoshi Tanegashima, Shigehiro Tsukahara, et al.
Scientific Reports|March 9, 2022
Mitochondrial dysfunction-induced high hCG associated with development of fetal growth restriction and pre-eclampsia with fetal growth restrictionRyo Kiyokoba, Takeshi Uchiumi, Mikako Yagi, et al.
The Prostate|July 11, 2024
Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration-resistant prostate cancer patientsTokiyoshi Tanegashima, Masaki Shiota, Shigehiro Tsukahara, et al.
Pageof 5